Answers are grounded in this paper and cite their sources.
A complex, yet coordinated cellular network drives the biological system of a cancer cell. This network, governed by the dynamic regulatory activity of the epigenome, genome, transcriptome, proteome, metabolome, repairome, and immunome, and more, reflects a cancer cell’s journey to uncontrolled growth, invasion, and metastasis. The multiome is therefore the foundation on which activity and disease are built. Current clinical-grade diagnostic methods depend heavily on genomics and transcriptomics, aided by a few supportive proteomic assays. Relying on limited omic strata restricts us from comprehending the entirety of a cancer cell’s behavior. Therefore, gaps in our understanding of how gene regulation operates across multiple omic layers hinder therapeutic approaches and limit our ability to effectively prosecute cancer resistance. Our perspective delves into the complex regulatory network dictating cancer biology and highlights the framework for practical integration of multiomic approaches and N-of-1 individualized, precision therapies, offering next-generation treatment strategies for patients with cancer.
No takes yet. Share an insight, caveat, or question.
I et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: